Prevention of peritoneal dialysis-related infections

Nephrology Dialysis Transplantation

Volumn 30, Issue 9, 2015, Pages 1461-1472

  Campbell, Denise J ^a,b   Johnson, David W ^c   Mudge, David W ^c   Gallagher, Martin P ^d   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Catheter related infections; exit site; peritoneal dialysis; peritonitis; randomized controlled trial

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; GENTAMICIN; POLYSPORIN; PSEUDOMONIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL PERITONITIS; CATHETER INFECTION; CATHETERIZATION; DRUG USE; EQUIPMENT DESIGN; HUMAN; INFECTION PREVENTION; INTERMETHOD COMPARISON; MYCOSIS; PATIENT CARE; PATIENT EDUCATION; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS CATHETER; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ADVERSE EFFECTS; FLUID THERAPY; INFECTION;

ANTI-BACTERIAL AGENTS; FLUID THERAPY; HUMANS; INFECTION; PERITONEAL DIALYSIS;

EID: 84940654620     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu313     Document Type: Review

References (57)

1. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; 70: S55-S62
2. Afolalu B, Troidle L, Osayimwen O et al. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit Dial Int 2009; 29: 292-296
3. Brown F, Gulyani A, Dent H et al. Peritoneal dialysis. In: McDonald S, Clayton P, Hurst K (eds). ANZDATA Registry Report 2011. ANZDATA Registry: Adelaide, SA, 2012, 61-632
4. Kutner NG, Zhang R, Barnhart H et al. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 2159-2167
5. Lo W-K. Peritoneal dialysis utilization and outcome: what are we facing? Perit Dial Int 2007; 27(Suppl 2): S42-S47
6. Davies SJ, Bryan J, Phillips L et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506
7. Strippoli GFM, Tong A, Johnson D et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; CD004679.
8. Piraino B, Bernardini J, Brown E et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31: 614-630
9. Wilkie M, Jenkins S, Shrestha B et al. Peritoneal access. http://www.renal. org/guidelines/modules/peritoneal-access (4 August 2014, date last accessed)
10. Walker A, Bannister K, George C et al. KHA-CARI guideline: peritonitis treatment and prophylaxis. Nephrology (Carlton) 2014; 19: 69-71
11. Strippoli GFM, Tong A, Johnson D et al. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; CD004680.
12. Hagen SM, Lafranca JA, Ijzermans JNM et al. A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival. Kidney Int 2014; 85: 920-932
13. Eklund B, Honkanen E, Kyllonen L et al. Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 1997; 12: 2664-2666
14. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009; 29: 297-302
15. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004; 19: 2584-2591
16. Tsimoyiannis EC, Siakas P, Glantzounis G et al. Laparoscopic placement of the Tenckhoff catheter for peritoneal dialysis. Surg Laparosc Endosc Percutan Tech 2000; 10: 218-221
17. Gadallah MF, Pervez A, el-Shahawy MA et al. Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: a prospective randomized study on outcome. Am J Kidney Dis 1999; 33: 118-122
18. Wright MJ, Bel'eed K, Johnson BF et al. Randomized prospective comparison of laparoscopic and open peritoneal dialysis catheter insertion. Perit Dial Int 1999; 19: 372-375
19. Moncrief JW, Popovich RP, Broadrick LJ et al. The Moncrief-Popovich catheter. A new peritoneal access technique for patients on peritoneal dialysis. ASAIO J 1993; 39: 62-65
20. Spence PA, Mathews RE, Khanna R et al. Improved results with a paramedian technique for the insertion of peritoneal dialysis catheters. Surg Gynecol Obstet 1985; 161: 585-587
21. Li PK-T, Szeto CC, Piraino B et al. Peritoneal dialysis-related infections recommendations: 2010 update [Erratum appears in Perit Dial Int 2011 Sep-Oct; 31(5): 512]. Perit Dial Int 2010; 30: 393-423
22. Hall G, Bogan A, Dreis S et al. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004; 31: 149-154, 159-163
23. Gadola L, Poggi C, Poggio M et al. Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. Perit Dial Int 2013; 33: 38-45
24. Bordin G, Casati M, Sicolo N et al. Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 2007; 33: 165-171
25. Holloway M, Mujais S, Kandert M et al. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Perit Dial Int 2001; 21: 401-404
26. Chen T-W, Li S-Y, Chen J-Y et al. Training of peritoneal dialysis patients-Taiwan's experiences. Perit Dial Int 2008; 28(Suppl 3): S72-S75
27. Bernardini J, Price V, Figueiredo A et al. International survey of peritoneal dialysis training programs. Perit Dial Int 2006; 26: 658-663
28. Ellis EN, Blaszak C, Wright S et al. Effectiveness of home visits to pediatric peritoneal dialysis patients. Perit Dial Int 2012; 32: 419-423
29. Russo R, Manili L, Tiraboschi G et al. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int 2006; 70: S127-S132
30. Chow KM, Szeto CC, Law MC et al. Influence of peritoneal dialysis training nurses' experience on peritonitis rates. Clin J Am Soc Nephrol 2007; 2: 647-652
31. Yang Z, Xu R, Zhuo M et al. Advanced nursing experience is beneficial for lowering the peritonitis rate in patients on peritoneal dialysis. Perit Dial Int 2012; 32: 60-66
32. Bernardini J, Price V, Figueiredo A, International Society for Peritoneal Dialysis Nursing Liaison C. Peritoneal dialysis patient training, 2006. Perit Dial Int 2006; 26: 625-632
33. Farrington K, Warwick G. RA guidelines-planning, initiating and withdrawal of renal replacement therapy. http://www.renal.org/pages/pages/guidelines/current/rrt.php
34. Woodrow G, Davies S. Peritoneal dialysis in CKD. http://www.renal.org/guidelines/modules/peritoneal-dialysis-in-ckd
35. Daly C, Campbell M, Cody J et al. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in endstage renal disease. Cochrane Database Syst Rev 2000; 3: CD003078.
36. Bazzato G, Coli U, Landini S et al. The double bag system for CAPD reduces the peritonitis rate. Trans Am Soc Artif Intern Organs 1984; 30: 690-692
37. Strippoli GFM, Tong A, Johnson D et al. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 2735-2746
38. Luzar M, Coles G, Faller B et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322: 505-509
39. Zimmerman S, Ahrens E, Johnson C et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18: 225-231
40. Piraino B. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it Effective? Nephrol Dial Transplant 2010; 25: 349-352
41. Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 587-592
42. Bernardini J, Bender F, Florio T et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-545
43. Pierce DA, Williamson JC, Mauck VS et al. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int 2012; 32: 525-530
44. Johnson DW, van Eps C, Mudge DW et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1456-1462
45. Johnson DW, Badve SV, Pascoe EM et al. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis 2014; 14: 23-30
46. McQuillan RF, Chiu E, Nessim S et al. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol 2012; 7: 297-303
47. Nunez-Moral M, Sanchez-Alvarez E, Gonzalez-Diaz I et al. Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. Results of a prospective randomized trial. Perit Dial Int 2014; 34: 271-277
48. Strippoli GFM, Tong A, Johnson D et al. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44: 591-603
49. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403-2408
50. Davey P, Craig AM, Hau C et al. Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial. J Antimicrob Chemother 1999; 43: 105-112
51. Perez-Fontan M, Rosales M, Rodriguez-Carmona A et al. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337-341
52. De Vriese AS, Vandecasteele SJ. Vancomycin: the tale of the vanquisher and the pyrrhic victory. Perit Dial Int 2014; 34: 154-161
53. Fried L, Bernardini J, Piraino B. Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 2000; 20: 343-345
54. Miles R, Hawley CM, McDonald SP et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622-628
55. Lo WK, Chan CY, Cheng SW et al. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549-552
56. Strippoli G, Wiggins K, Johnson D et al. Prevention and treatment of peritoneal dialysis-related infections. In: Molony D, Craig J (eds). Evidence-Based Nephrology. Oxford: Blackwell Publishing, 2009, pp. 509-532
57. Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. [Erratum appears in Perit Dial Int 2011 Mar-Apr; 31(2):120]. Perit Dial Int 2010; 30: 619-625